Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.57 |
| ▸ | SQLE | Q14534 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8657303 | 1.00 | KMT2A (0.64) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL24434263 | 0.98 | KMT2A (0.67) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL15158145 | 0.98 | KMT2A (0.67) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL12818876 | 0.91 | KMT2A (0.70) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL27843331 | 0.91 | KMT2A (0.70) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Squalene SCHEMBL27987016 | 0.91 | KMT2A (0.77) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| Squalene SCHEMBL6425147 | 0.91 | KMT2A (0.77) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL2992758 | 0.91 | KMT2A (0.70) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL4663422 | 0.91 | KMT2A (0.70) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL6425146 | 0.90 | SQLE (0.69) | KMT2AMAPTMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1919858-A2 | MANAGEMENT OF OPHTHALMOLOGIC DISORDERS, INCLUDING MACULAR DEGENERATION | The President and Fellows of Harvard College (US) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007019503-A2 | MANAGEMENT OF OPHTHALMOLOGIC DISORDERS, INCLUDING MACULAR DEGENERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-02-15 | — | — | WO | disclosed |